| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 1.87e-05 | 61 | 181 | 6 | GO:0008408 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 8.39e-05 | 10 | 181 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 8.70e-05 | 199 | 181 | 9 | GO:1901981 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 1.19e-04 | 121 | 181 | 7 | GO:1902936 | |
| GeneOntologyMolecularFunction | histone binding | 1.58e-04 | 265 | 181 | 10 | GO:0042393 | |
| GeneOntologyMolecularFunction | exonuclease activity | 1.91e-04 | 92 | 181 | 6 | GO:0004527 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP7A PSMC3 PSMC4 MCM2 MDN1 NAV3 HSP90AB2P ATP1A2 ATP1A3 DNAH6 ATP2A3 AQR MOV10 | 2.01e-04 | 441 | 181 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 2.28e-04 | 95 | 181 | 6 | GO:0005546 | |
| GeneOntologyMolecularFunction | copper-dependent protein binding | 2.44e-04 | 3 | 181 | 2 | GO:0032767 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.47e-04 | 62 | 181 | 5 | GO:0016796 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.07e-04 | 36 | 181 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.07e-04 | 36 | 181 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 3.41e-04 | 37 | 181 | 4 | GO:0000175 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 4.63e-04 | 40 | 181 | 4 | GO:0016896 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP7A MYO10 PSMC3 PSMC4 MCM2 MSH6 MDN1 NAV3 HSP90AB2P ATP1A2 ATP1A3 DNAH6 ATP2A3 AQR MOV10 | 4.92e-04 | 614 | 181 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 6.38e-04 | 316 | 181 | 10 | GO:0035091 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 6.68e-04 | 44 | 181 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 7.28e-04 | 45 | 181 | 4 | GO:0004532 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 7.45e-04 | 20 | 181 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | box H/ACA snoRNA binding | 8.03e-04 | 5 | 181 | 2 | GO:0034513 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | XRN2 DIS3L2 ANG IARS1 POLG LARS1 MCM2 PNPT1 MSH6 ANGEL2 DKC1 HARS1 AQR MOV10 SMG6 | 8.15e-04 | 645 | 181 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PPP4R1 XRN2 DIS3L2 ANG IARS1 POLG LARS1 NME8 CTDSP2 PNPT1 PTPN13 ANGEL2 ASPA ATP1A2 UBASH3B PDE11A SMG6 | 1.10e-03 | 807 | 181 | 17 | GO:0016788 |
| GeneOntologyMolecularFunction | fibrinogen binding | 1.20e-03 | 6 | 181 | 2 | GO:0070051 | |
| GeneOntologyMolecularFunction | proteasome-activating activity | 1.20e-03 | 6 | 181 | 2 | GO:0036402 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.25e-03 | 231 | 181 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.52e-03 | 136 | 181 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | XRN2 DIS3L2 ANG IARS1 LARS1 PNPT1 ANGEL2 HARS1 AQR MOV10 SMG6 | 1.52e-03 | 417 | 181 | 11 | GO:0140098 |
| GeneOntologyMolecularFunction | steroid hormone binding | 1.67e-03 | 7 | 181 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | BMP receptor activity | 2.21e-03 | 8 | 181 | 2 | GO:0098821 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 2.21e-03 | 8 | 181 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.42e-03 | 62 | 181 | 4 | GO:0019829 | |
| Domain | N-SET | 9.03e-05 | 2 | 178 | 2 | PF11764 | |
| Domain | N-SET | 9.03e-05 | 2 | 178 | 2 | SM01291 | |
| Domain | COMPASS_Set1_N-SET | 9.03e-05 | 2 | 178 | 2 | IPR024657 | |
| Domain | - | 2.33e-04 | 32 | 178 | 4 | 3.40.1110.10 | |
| Domain | - | 2.33e-04 | 32 | 178 | 4 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 3.32e-04 | 35 | 178 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 3.70e-04 | 36 | 178 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 3.70e-04 | 36 | 178 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 3.70e-04 | 36 | 178 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.12e-04 | 37 | 178 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.12e-04 | 37 | 178 | 4 | PF00122 | |
| Domain | ATPase_P-typ_TM_dom | 4.35e-04 | 16 | 178 | 3 | IPR023298 | |
| Domain | - | 4.35e-04 | 16 | 178 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 5.25e-04 | 17 | 178 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 5.25e-04 | 17 | 178 | 3 | PF00689 | |
| Domain | Nebulin | 5.35e-04 | 4 | 178 | 2 | PF00880 | |
| Domain | Ubiquitin_3 | 5.35e-04 | 4 | 178 | 2 | PF14836 | |
| Domain | Ub_USP-typ | 5.35e-04 | 4 | 178 | 2 | IPR028135 | |
| Domain | NEBULIN | 5.35e-04 | 4 | 178 | 2 | PS51216 | |
| Domain | NEBU | 5.35e-04 | 4 | 178 | 2 | SM00227 | |
| Domain | Nebulin | 5.35e-04 | 4 | 178 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 5.35e-04 | 4 | 178 | 2 | IPR000900 | |
| Domain | SET | 6.13e-04 | 41 | 178 | 4 | PF00856 | |
| Domain | Cation_ATPase_N | 6.25e-04 | 18 | 178 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 6.25e-04 | 18 | 178 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 7.37e-04 | 19 | 178 | 3 | IPR004014 | |
| Domain | HAD-like_dom | 9.48e-04 | 79 | 178 | 5 | IPR023214 | |
| Domain | SET | 9.52e-04 | 46 | 178 | 4 | SM00317 | |
| Domain | SET_dom | 1.30e-03 | 50 | 178 | 4 | IPR001214 | |
| Domain | SET | 1.30e-03 | 50 | 178 | 4 | PS50280 | |
| Domain | DUSP | 1.32e-03 | 6 | 178 | 2 | PF06337 | |
| Domain | 26S_Psome_P45 | 1.32e-03 | 6 | 178 | 2 | IPR005937 | |
| Domain | DUSP | 1.32e-03 | 6 | 178 | 2 | SM00695 | |
| Domain | Val/Leu/Ile-tRNA-synth_edit | 1.32e-03 | 6 | 178 | 2 | IPR009008 | |
| Domain | Anticodon_1 | 1.32e-03 | 6 | 178 | 2 | PF08264 | |
| Domain | P-type_ATPase_IIC | 1.32e-03 | 6 | 178 | 2 | IPR005775 | |
| Domain | M/V/L/I-tRNA-synth_anticd-bd | 1.32e-03 | 6 | 178 | 2 | IPR013155 | |
| Domain | - | 1.32e-03 | 6 | 178 | 2 | 3.90.740.10 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 SART3 VIM SETD1A XRN2 DIS3L2 SETD1B L3MBTL2 PDLIM7 IARS1 ESYT1 CAPN1 NOC3L LARS1 PSMC3 ISOC1 PSMC4 MCM2 OAS3 MSH6 MDN1 GTF3C1 VPS33B DKC1 HSP90AB2P SEC23A AQR MOV10 TP53BP2 | 1.52e-10 | 1353 | 184 | 29 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 SART3 XRN2 COL17A1 RBM12B IARS1 ESYT1 CAPN1 NOC3L LARS1 ISOC1 OAS3 PPHLN1 APOBEC3B PDCD4 KRT80 MRPL39 MSH6 MISP GTF3C1 ANGEL2 SVIL FKBP4 AQR CBX8 SDHA MOV10 | 6.72e-10 | 1257 | 184 | 27 | 36526897 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 VIM SETD1A XRN2 RIOK1 ACACB IARS1 ESYT1 NOC3L LARS1 KDM3B PSMC3 PSMC4 MCM2 APOBEC3B PDCD4 MRPL39 METAP1 MSH6 MDN1 FAM111A DKC1 RP9 FH AQR SDHA MOV10 | 1.86e-09 | 1318 | 184 | 27 | 30463901 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 SART3 VIM XRN2 RIOK1 IARS1 ESYT1 RTN4 NOC3L LARS1 PSMC3 PSMC4 MCM2 MSH6 ERLIN2 MDN1 GTF3C1 DAZAP1 VPS33B SUPT6H DKC1 SMARCE1 HARS1 FH FKBP4 SEC23A AQR SDHA | 2.25e-09 | 1425 | 184 | 28 | 30948266 |
| Pubmed | SART3 IARS1 ESYT1 LARS1 KDM3B PSMC3 PSMC4 MCM2 PPHLN1 MSH6 MDN1 GTF3C1 VPS33B SMARCE1 FKBP4 | 4.16e-09 | 399 | 184 | 15 | 37536630 | |
| Pubmed | NOLC1 VIM RBM12B MYO10 IARS1 RTN4 LARS1 PSMC3 PSMC4 MCM2 PDCD4 PNPO MDN1 DKC1 HSP90AB2P FH MOV10 | 5.00e-09 | 538 | 184 | 17 | 28524877 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | VIM VPS26B IARS1 ESYT1 XDH MCM2 OAS3 ITGA2B CBL MDN1 USP4 UBASH3B SEC23A MOV10 | 5.11e-09 | 344 | 184 | 14 | 30333137 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 SART3 VIM RIOK1 ACACB L3MBTL2 ESYT1 RTN4 NOC3L LARS1 KDM3B SIN3A PDCD4 MSH6 PTPN13 R3HCC1L SENP6 DKC1 SMARCE1 DEPDC1B FKBP4 TP53BP2 | 5.71e-09 | 934 | 184 | 22 | 33916271 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NOLC1 SART3 VIM EXOC6 XRN2 RIOK1 PDLIM7 IARS1 ESYT1 LARS1 PSMC3 PSMC4 MCM2 TSC2 NME8 SMYD2 MRPL39 PTPN13 ERLIN2 ANKRD34A HSP90AB2P DEPDC1B MOV10 MAST3 TP53BP2 CHST3 | 8.69e-09 | 1321 | 184 | 26 | 27173435 |
| Pubmed | SETD1A RIOK1 PCGF1 SETD1B GRK5 CAPN1 KDM3B BRD3 KCNH4 METAP1 BMI1 BMPR1A RPS6KA6 LRP2 USP4 HARS1 ATP1A2 ATP1A3 SEC23A | 1.39e-08 | 730 | 184 | 19 | 34857952 | |
| Pubmed | PPP4R1 VIM XRN2 ADAM23 POLG CNTNAP1 LARS1 TSC2 DSCAML1 SMYD2 METAP1 PTPN13 DAZAP1 CIAO3 ASPA USP32 NAV3 LRP2 SENP6 SMARCE1 ALAD HARS1 ATP1A2 CADPS2 SDHA | 2.17e-08 | 1285 | 184 | 25 | 35914814 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SART3 VIM SETD1A IARS1 NOC3L LARS1 MCM2 BRD3 SIN3A MDN1 GTF3C1 TONSL DKC1 CBX8 | 2.81e-08 | 394 | 184 | 14 | 27248496 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SART3 XRN2 VPS26B CAPN1 LARS1 PSMC3 PSMC4 MCM2 SIN3A MSH6 GTF3C1 DAZAP1 VPS33B SMARCE1 ATP1A2 ATP2A3 FKBP4 MOV10 | 4.46e-08 | 704 | 184 | 18 | 29955894 |
| Pubmed | SART3 VIM XRN2 RIOK1 IARS1 LARS1 PSMC3 ISOC1 PSMC4 MCM2 MRPL45 CUL5 MRPL17 MRPL39 MSH6 GTF3C1 FBXO3 ANGEL2 DKC1 SMARCE1 HSP90AB2P SLC25A48 SEC23A SDHA MOV10 | 4.53e-08 | 1335 | 184 | 25 | 29229926 | |
| Pubmed | NOLC1 SART3 XRN2 ESYT1 RTN4 TOM1 NOC3L LARS1 PSMC3 PSMC4 MCM2 OAS3 TSC2 RELB MRPL45 PDCD4 CUL5 MSH6 ERLIN2 MDN1 GTF3C1 DKC1 HSP90AB2P SDHA MOV10 EVI5L | 4.88e-08 | 1440 | 184 | 26 | 30833792 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | VIM XRN2 IARS1 ESYT1 RTN4 CAPN1 LARS1 PSMC3 ISOC1 PSMC4 MSH6 ERLIN2 MDN1 TONSL EML1 HARS1 FH FKBP4 SEC23A | 6.73e-08 | 807 | 184 | 19 | 30575818 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NOLC1 VIM XRN2 PDLIM7 IARS1 ESYT1 RTN4 CAPN1 TOM1 NOC3L KDM3B PSMC4 OAS3 SIN3A APOBEC3B KRT80 MRPL39 METAP1 MSH6 MISP PTGR1 SMARCE1 FH FKBP4 SEC23A | 7.12e-08 | 1367 | 184 | 25 | 32687490 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 VIM XRN2 RBM12B PDLIM7 ESYT1 NOC3L PSMC3 PSMC4 MCM2 PPHLN1 SIN3A METAP1 MSH6 MDN1 GTF3C1 DAZAP1 SUPT6H DKC1 HSP90AB2P FKBP4 | 7.54e-08 | 989 | 184 | 21 | 36424410 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RIOK1 ACACB RTN4 OBSCN PSMC4 BRD3 NEB ERLIN2 MDN1 GTF3C1 AGA USP32 DIAPH2 RP1 ATP2A3 | 7.54e-08 | 497 | 184 | 15 | 36774506 |
| Pubmed | NOLC1 SART3 XRN2 CAPN1 NOC3L PSMC3 PNPT1 MSH6 MDN1 GTF3C1 SUPT6H FH FKBP4 SEC23A AQR SDHA MOV10 | 8.33e-08 | 653 | 184 | 17 | 22586326 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A SETD1B MYO10 ESYT1 POLG GRK5 OBSCN KDM3B TSC2 RELB CTDSP2 FZD7 MGAT1 NADSYN1 MDN1 DIAPH2 ANKRD34A ATP2A3 SDHA EVI5L ANKRD16 SMG6 | 1.10e-07 | 1105 | 184 | 22 | 35748872 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.17e-07 | 150 | 184 | 9 | 28242625 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 SART3 VIM RIOK1 IARS1 LARS1 PSMC3 ISOC1 PSMC4 MCM2 TSC2 SIN3A PDCD4 MRPL39 PNPT1 MSH6 DAZAP1 FBXO3 SUPT6H DKC1 SMARCE1 HSP90AB2P SEC23A AQR SDHA | 1.37e-07 | 1415 | 184 | 25 | 28515276 |
| Pubmed | NOLC1 SETD1A XRN2 PCGF1 MED10 ACACB L3MBTL2 IARS1 NOC3L LARS1 MSANTD2 PSMC3 PSMC4 RELB SIN3A ZNF3 MRPL17 MRPL39 ERLIN2 GTF3C1 SVIL LRP2 SMARCE1 FKBP4 MOV10 | 1.65e-07 | 1429 | 184 | 25 | 35140242 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 SART3 SETD1A NOC3L KDM3B TSC2 SIN3A CUL5 MISP GTF3C1 GREB1 AQR | 3.15e-07 | 341 | 184 | 12 | 32971831 |
| Pubmed | NOLC1 EXOC6 NRAP COL17A1 CDHR1 GRK5 NOC3L PDCD4 BMPR1A R3HCC1L CLRN3 SVIL CHST3 | 3.77e-07 | 415 | 184 | 13 | 16385451 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NOLC1 VIM ESYT1 POLG RTN4 PSMC3 PSMC4 TSC2 MRPL45 MRPL17 MRPL39 PNPT1 ERLIN2 MDN1 VPS33B ATP6AP2 ANGEL2 LRP2 DKC1 DEPDC1B FKBP4 SEC23A SDHA MOV10 SMG6 | 3.86e-07 | 1496 | 184 | 25 | 32877691 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SART3 MYO10 IARS1 NOC3L KDM3B PSMC3 PSMC4 MCM2 MRPL45 BTBD9 PDCD4 CUL5 MRPL39 FBXO3 SUPT6H ATP6AP2 USP32 DKC1 USP4 AQR | 4.37e-07 | 1005 | 184 | 20 | 19615732 |
| Pubmed | ATP7A VPS26B ESYT1 RTN4 TOM1 TSC2 CTDSP2 PTPN13 VPS33B ATP6AP2 USP32 DIAPH2 LRP2 SEC23A | 5.62e-07 | 504 | 184 | 14 | 34432599 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | VIM ACACB IARS1 LARS1 PSMC3 PSMC4 MCM2 BRD3 ERLIN2 DAZAP1 SMARCE1 RP9 ATP1A2 ATP1A3 FH SEC23A | 5.79e-07 | 665 | 184 | 16 | 30457570 |
| Pubmed | SART3 VIM ILDR2 DPP6 IARS1 RTN4 CNTNAP1 TOM1 LARS1 PSMC3 CUL5 NPTN MISP ERLIN2 SPON1 SVIL USP4 ATP1A2 ATP1A3 FH DNAH6 SEC23A SDHA TP53BP2 | 6.33e-07 | 1431 | 184 | 24 | 37142655 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SART3 SETD1A XRN2 SETD1B ESYT1 NOC3L MCM2 MSH6 GTF3C1 SUPT6H DKC1 AQR MOV10 | 7.28e-07 | 440 | 184 | 13 | 34244565 |
| Pubmed | SETD1A MED10 PSMC3 PSMC4 SIN3A MRPL17 NPTN MDN1 FAM111A GTF3C1 DAZAP1 TONSL SMARCE1 | 1.01e-06 | 453 | 184 | 13 | 29656893 | |
| Pubmed | 1.17e-06 | 101 | 184 | 7 | 9872452 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | NOLC1 VIM XRN2 ACOX1 RTN4 TOM1 CIR1 PSMC3 PSMC4 PPHLN1 PDCD4 DAZAP1 SMARCE1 HARS1 FH FKBP4 | 1.22e-06 | 704 | 184 | 16 | 32994395 |
| Pubmed | NOLC1 SETD1A XRN2 MCM2 BRD3 SIN3A EZH1 GTF3C1 DAZAP1 SUPT6H ANGEL2 AQR MOV10 | 1.48e-06 | 469 | 184 | 13 | 27634302 | |
| Pubmed | VIM XRN2 RIOK1 L3MBTL2 IARS1 LARS1 PSMC4 PPHLN1 PDCD4 ANGEL2 DKC1 FH AQR MOV10 | 1.60e-06 | 551 | 184 | 14 | 34728620 | |
| Pubmed | SART3 VIM XRN2 IARS1 ESYT1 LARS1 PSMC3 PSMC4 MCM2 SIN3A MDN1 SUPT6H DKC1 FKBP4 SEC23A | 1.76e-06 | 638 | 184 | 15 | 33239621 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | SETD1A XRN2 NOC3L OAS3 PPHLN1 MRPL45 APOBEC3B CUL5 MRPL17 FAM111A GTF3C1 MOV10 | 2.17e-06 | 410 | 184 | 12 | 26949251 |
| Pubmed | NOLC1 SART3 SETD1A XRN2 IARS1 LARS1 PSMC3 PSMC4 MCM2 HSP90AB2P FKBP4 SEC23A MOV10 | 2.61e-06 | 494 | 184 | 13 | 26831064 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NOLC1 PPP4R1 SART3 VIM GNPDA1 IARS1 CAPN1 TOM1 LARS1 KDM3B PSMC3 ISOC1 PSMC4 MCM2 PDCD4 CUL5 MSH6 ALAD HSP90AB2P HARS1 FH FKBP4 SEC23A | 2.98e-06 | 1455 | 184 | 23 | 22863883 |
| Pubmed | NOLC1 VIM MED10 PDLIM7 IARS1 RTN4 CAPN1 LARS1 PSMC3 PSMC4 PDCD4 PNPT1 BMPR1A ERLIN2 SVIL ATP1A3 FH FKBP4 AQR SDHA TP53BP2 | 3.16e-06 | 1247 | 184 | 21 | 27684187 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | SART3 IARS1 RTN4 TOM1 LARS1 EZH1 DSCAML1 BMPR1A SUPT6H EML1 MOV10 | 3.66e-06 | 358 | 184 | 11 | 32460013 |
| Pubmed | 5.29e-06 | 237 | 184 | 9 | 29564676 | ||
| Pubmed | NOLC1 SART3 SETD1A RTN4 LARS1 KDM3B MCM2 METAP1 SUPT6H SENP6 ATP1A2 HPS5 SMG6 | 5.47e-06 | 529 | 184 | 13 | 14621295 | |
| Pubmed | IARS1 ESYT1 RTN4 CNTNAP1 TOM1 LARS1 KDM3B CIR1 PSMC3 PSMC4 MCM2 RELB PNPO MISP ERLIN2 FBXO3 ATP6AP2 RP9 HARS1 FKBP4 AQR | 5.77e-06 | 1297 | 184 | 21 | 33545068 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 MED10 CAPN1 BRD3 BMI1 MSH6 PTPN13 MDN1 GTF3C1 TONSL DKC1 SMARCE1 CBX8 | 5.93e-06 | 533 | 184 | 13 | 30554943 |
| Pubmed | NOLC1 IARS1 RTN4 CAPN1 CNTNAP1 LARS1 CUL5 FBXO3 ATP2A3 FKBP4 SDHA SMG6 | 6.53e-06 | 457 | 184 | 12 | 22190034 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | NOLC1 SART3 SETD1A TSC2 BMPR1A PTPN13 ERLIN2 GTF3C1 SVIL DEPDC1B | 7.27e-06 | 313 | 184 | 10 | 38270169 |
| Pubmed | NOLC1 SART3 XRN2 KDM3B MCM2 PPHLN1 BRD3 SIN3A CUL5 MSH6 MDN1 GTF3C1 PTGR1 SUPT6H DKC1 SMARCE1 FKBP4 AQR | 8.22e-06 | 1014 | 184 | 18 | 32416067 | |
| Pubmed | PCGF1 ACACB MUC16 MCM2 TSC2 SIN3A MRPL17 BMI1 MSH6 ANGEL2 CBX8 | 9.47e-06 | 396 | 184 | 11 | 26687479 | |
| Pubmed | NOLC1 SART3 VIM XRN2 IARS1 LARS1 CIR1 SIN3A MSH6 MISP GTF3C1 RP9 SDHA MOV10 | 1.15e-05 | 655 | 184 | 14 | 35819319 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EXOC6 IARS1 ESYT1 RTN4 TOM1 NOC3L LARS1 PSMC3 PSMC4 TSC2 NPTN MGAT1 ERLIN2 ATP6AP2 ATP1A3 SEC23A SDHA | 1.20e-05 | 942 | 184 | 17 | 31073040 |
| Pubmed | 1.24e-05 | 333 | 184 | 10 | 36779763 | ||
| Pubmed | NOLC1 VIM XRN2 RBM12B PSMC3 PSMC4 KRT80 METAP1 ORC5 MISP ERLIN2 DAZAP1 SVIL DKC1 | 1.25e-05 | 660 | 184 | 14 | 32780723 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SART3 IARS1 LARS1 PSMC3 PSMC4 MCM2 MRPL17 MSH6 ERLIN2 MDN1 SUPT6H HSP90AB2P HARS1 DNAH6 FKBP4 SDHA | 1.25e-05 | 847 | 184 | 16 | 35235311 |
| Pubmed | NOLC1 SART3 ATP7A L3MBTL2 ESYT1 RTN4 NOC3L PSMC4 MRPL45 MRPL17 MRPL39 PNPT1 PTPN13 R3HCC1L MDN1 SUPT6H ATP6AP2 DEPDC1B FKBP4 AQR SDHA MAST3 | 1.40e-05 | 1487 | 184 | 22 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DPP6 CPAMD8 TMPRSS6 POLG CAPN1 TOM1 OBSCN PPHLN1 BTBD9 CUL5 BMPR2 PTPN13 NADSYN1 FAM111A GTF3C1 DAZAP1 SUPT6H GREB1 HPS5 RPS6KL1 EVI5L SMG6 | 1.43e-05 | 1489 | 184 | 22 | 28611215 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | SETD1A PCGF1 SETD1B L3MBTL2 PSMC3 PSMC4 SIN3A EZH1 BMI1 ERLIN2 FBXO3 CBX8 | 1.45e-05 | 495 | 184 | 12 | 27705803 |
| Pubmed | XRN2 PCGF1 L3MBTL2 NOC3L KDM3B SIN3A GTF3C1 SENP6 DKC1 SMARCE1 | 1.45e-05 | 339 | 184 | 10 | 30415952 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | NOLC1 VIM XRN2 RIOK1 PDLIM7 PSMC3 PSMC4 ORC5 MSH6 MDN1 VPS33B SEC23A AQR | 1.51e-05 | 582 | 184 | 13 | 20467437 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SART3 VIM XRN2 GNPDA1 ESYT1 RTN4 LARS1 MCM2 MSH6 SVIL FKBP4 AQR | 1.54e-05 | 498 | 184 | 12 | 36634849 |
| Pubmed | SART3 PDLIM7 ESYT1 TOM1 NOC3L PPHLN1 BRD3 METAP1 ORC5 MSH6 MGAT1 PTPN13 MDN1 SUPT6H ATP6AP2 SMARCE1 HSP90AB2P AQR CBX8 SDHA MOV10 SMG6 | 1.55e-05 | 1497 | 184 | 22 | 31527615 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 1.61e-05 | 150 | 184 | 7 | 30154076 | |
| Pubmed | 1.62e-05 | 29 | 184 | 4 | 15071553 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.86e-05 | 212 | 184 | 8 | 33462405 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PCGF1 L3MBTL2 KDM3B BRD3 SIN3A ZNF226 BMI1 ORC5 MSH6 GTF3C1 SENP6 SMARCE1 CBX8 | 2.37e-05 | 608 | 184 | 13 | 36089195 |
| Pubmed | 2.43e-05 | 32 | 184 | 4 | 36278411 | ||
| Pubmed | 2.59e-05 | 222 | 184 | 8 | 35941108 | ||
| Pubmed | FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates. | 2.68e-05 | 223 | 184 | 8 | 34226595 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 2.75e-05 | 33 | 184 | 4 | 26864203 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 28331227 | ||
| Pubmed | cDNA cloning and genomic organization of the mouse BMP type II receptor. | 2.78e-05 | 2 | 184 | 2 | 9207184 | |
| Pubmed | The structure of the Na+,K+-ATPase and mapping of isoform differences and disease-related mutations. | 2.78e-05 | 2 | 184 | 2 | 18957371 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22879973 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 34910522 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17716656 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 35384384 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 34078089 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 30796192 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 16487966 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11687802 | ||
| Pubmed | ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. | 2.78e-05 | 2 | 184 | 2 | 33880529 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24550110 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 20123970 | ||
| Pubmed | Archvillin anchors in the Z-line of skeletal muscle via the nebulin C-terminus. | 2.78e-05 | 2 | 184 | 2 | 18639526 | |
| Pubmed | In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). | 2.78e-05 | 2 | 184 | 2 | 38003223 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 28588028 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24356962 | ||
| Pubmed | NOLC1 SART3 VIM ACACB GRK5 NOC3L BRD3 NEB BMPR1A ERLIN2 MDN1 GTF3C1 CLRN3 CIAO3 DKC1 ATP1A2 ATP1A3 CADPS2 DNAH6 ATP2A3 SLC6A14 | 2.80e-05 | 1442 | 184 | 21 | 35575683 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | VIM XRN2 RBM12B IARS1 PSMC3 PSMC4 MCM2 PPHLN1 APOBEC3B MRPL39 DAZAP1 HSP90AB2P AQR MOV10 | 2.97e-05 | 714 | 184 | 14 | 28302793 |
| Pubmed | Role for the MOV10 RNA helicase in polycomb-mediated repression of the INK4a tumor suppressor. | 3.09e-05 | 12 | 184 | 3 | 20543829 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 3.35e-05 | 69 | 184 | 5 | 28481362 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 XRN2 RBM12B PDLIM7 IARS1 LARS1 MCM2 KRT80 MDN1 GTF3C1 DAZAP1 SUPT6H SVIL DKC1 FKBP4 SEC23A AQR | 3.44e-05 | 1024 | 184 | 17 | 24711643 |
| Pubmed | β-Catenin regulates endocardial cushion growth by suppressing p21. | 3.49e-05 | 35 | 184 | 4 | 37385754 | |
| Pubmed | 3.70e-05 | 116 | 184 | 6 | 21549307 | ||
| Pubmed | 3.74e-05 | 171 | 184 | 7 | 36629882 | ||
| Pubmed | 4.01e-05 | 13 | 184 | 3 | 18986647 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | VIM XRN2 IARS1 ESYT1 TOM1 LARS1 PSMC3 PSMC4 TSC2 ORC5 MSH6 ERLIN2 MDN1 GTF3C1 DAZAP1 DKC1 HSP90AB2P SEC23A SDHA | 4.20e-05 | 1257 | 184 | 19 | 37317656 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | SART3 VIM RIOK1 IARS1 TOM1 LARS1 PSMC3 PSMC4 MCM2 MSH6 MDN1 LRRIQ1 GTF3C1 SVIL HARS1 FKBP4 SEC23A MOV10 | 4.27e-05 | 1149 | 184 | 18 | 35446349 |
| Interaction | ITGB3 interactions | 4.05e-07 | 170 | 181 | 11 | int:ITGB3 | |
| Interaction | EED interactions | NOLC1 VIM XRN2 PCGF1 ACACB L3MBTL2 RBM12B PDLIM7 IARS1 CAPN1 TOM1 NOC3L LARS1 OBSCN PSMC4 MCM2 PPHLN1 SIN3A EZH1 CBL APOBEC3B BMI1 MSH6 ERLIN2 GTF3C1 DAZAP1 SUPT6H SVIL DKC1 SEC23A AQR CBX8 MOV10 | 5.95e-07 | 1445 | 181 | 33 | int:EED |
| Interaction | H2AC4 interactions | SART3 VIM SETD1A PCGF1 IARS1 NOC3L LARS1 MCM2 CUL5 BMI1 MDN1 GTF3C1 SUPT6H SVIL TONSL DKC1 CBX8 SDHA | 7.56e-07 | 506 | 181 | 18 | int:H2AC4 |
| Interaction | H2AC17 interactions | SART3 SETD1A PCGF1 DIS3L2 NOC3L MCM2 CUL5 MRPL17 FAM111A TONSL DKC1 MOV10 | 1.31e-06 | 232 | 181 | 12 | int:H2AC17 |
| Interaction | NAA40 interactions | NOLC1 SART3 VIM RIOK1 ACACB L3MBTL2 ESYT1 RTN4 NOC3L LARS1 KDM3B MCM2 SIN3A PDCD4 METAP1 MSH6 PTPN13 R3HCC1L ANGEL2 SENP6 DKC1 SMARCE1 DEPDC1B FKBP4 TP53BP2 | 2.35e-06 | 978 | 181 | 25 | int:NAA40 |
| Interaction | PTPRB interactions | 6.22e-06 | 51 | 181 | 6 | int:PTPRB | |
| Interaction | H3C1 interactions | SETD1A RIOK1 PCGF1 SETD1B L3MBTL2 ESYT1 CAPN1 NOC3L MCM2 BRD3 SIN3A NEB PDCD4 BMI1 MSH6 GTF3C1 TONSL NAV3 SENP6 DKC1 AQR CBX8 MOV10 | 6.34e-06 | 901 | 181 | 23 | int:H3C1 |
| Interaction | TOP3B interactions | SETD1A RIOK1 SETD1B MYO10 IARS1 ESYT1 POLG GRK5 LARS1 OBSCN KDM3B TSC2 RELB CTDSP2 FZD7 MGAT1 NADSYN1 ERLIN2 MDN1 ATP6AP2 SVIL DIAPH2 ANKRD34A DKC1 ATP2A3 SEC23A SDHA MOV10 EVI5L ANKRD16 SMG6 | 7.11e-06 | 1470 | 181 | 31 | int:TOP3B |
| Interaction | H3C3 interactions | RIOK1 PCGF1 L3MBTL2 KDM3B MCM2 BRD3 SIN3A ZNF226 BMI1 ORC5 MSH6 GTF3C1 SUPT6H TONSL SMARCE1 CBX8 | 1.07e-05 | 495 | 181 | 16 | int:H3C3 |
| Interaction | H4C5 interactions | 1.25e-05 | 34 | 181 | 5 | int:H4C5 | |
| Interaction | SCML1 interactions | 1.47e-05 | 59 | 181 | 6 | int:SCML1 | |
| Interaction | CBX3 interactions | VIM SETD1A PCGF1 L3MBTL2 MSANTD2 MCM2 BRD3 RELB ZNF226 EZH1 BMI1 GTF3C1 DIAPH2 SENP6 SMARCE1 RP9 FKBP4 CBX8 | 2.21e-05 | 646 | 181 | 18 | int:CBX3 |
| Interaction | H2BC4 interactions | NOLC1 RIOK1 VPS26B MCM2 NEB PDCD4 BMI1 ATP1A3 FH SDHA TP53BP2 | 2.34e-05 | 259 | 181 | 11 | int:H2BC4 |
| Interaction | MOB3C interactions | SART3 IARS1 ESYT1 LARS1 KDM3B PSMC3 PSMC4 MCM2 MSH6 MDN1 GTF3C1 SMARCE1 FKBP4 | 2.65e-05 | 364 | 181 | 13 | int:MOB3C |
| Interaction | CD83 interactions | 2.81e-05 | 66 | 181 | 6 | int:CD83 | |
| Interaction | BMI1 interactions | SART3 XRN2 PCGF1 DIS3L2 L3MBTL2 ESYT1 PPHLN1 TSC2 CBL BMI1 GTF3C1 DAZAP1 SUPT6H DKC1 ATP2A3 AQR CBX8 MOV10 | 2.87e-05 | 659 | 181 | 18 | int:BMI1 |
| Interaction | AGR2 interactions | VIM XRN2 NRAP IARS1 ESYT1 RTN4 CAPN1 LARS1 PSMC3 ISOC1 PSMC4 APOBEC3B MSH6 ERLIN2 MDN1 PTGR1 TONSL EML1 HARS1 FH FKBP4 SEC23A | 3.51e-05 | 934 | 181 | 22 | int:AGR2 |
| Interaction | PARP1 interactions | NOLC1 SETD1A L3MBTL2 PDLIM7 NOC3L MSANTD2 MCM2 BRD3 SIN3A KRT80 BMI1 MSH6 PTPN13 NADSYN1 MDN1 GTF3C1 SUPT6H SVIL SENP6 DKC1 SMARCE1 ALAD SEC23A AQR CBX8 MOV10 MAST3 | 4.83e-05 | 1316 | 181 | 27 | int:PARP1 |
| Interaction | MEN1 interactions | NOLC1 SART3 VIM SETD1A XRN2 SETD1B IARS1 NOC3L KDM3B MCM2 PPHLN1 TSC2 SIN3A CUL5 MISP MDN1 GTF3C1 DKC1 SMARCE1 GREB1 AQR CBX8 MOV10 | 5.17e-05 | 1029 | 181 | 23 | int:MEN1 |
| Interaction | ZC3H4 interactions | 5.59e-05 | 147 | 181 | 8 | int:ZC3H4 | |
| Interaction | NR2C2 interactions | NOLC1 VIM SETD1A XRN2 RIOK1 ACACB PDLIM7 IARS1 ESYT1 NOC3L LARS1 KDM3B PSMC3 PSMC4 MCM2 APOBEC3B PDCD4 MRPL39 METAP1 MSH6 MDN1 FAM111A DKC1 RP9 FH AQR SDHA MOV10 | 5.60e-05 | 1403 | 181 | 28 | int:NR2C2 |
| Interaction | ZNF740 interactions | 6.87e-05 | 25 | 181 | 4 | int:ZNF740 | |
| Interaction | H4C16 interactions | 7.08e-05 | 152 | 181 | 8 | int:H4C16 | |
| Interaction | MKI67 interactions | SETD1A XRN2 PDLIM7 NOC3L MCM2 OAS3 PPHLN1 BRD3 MRPL45 APOBEC3B CUL5 MRPL17 BMI1 FAM111A GTF3C1 RPS6KA6 MOV10 | 7.92e-05 | 648 | 181 | 17 | int:MKI67 |
| Interaction | H4C3 interactions | 8.44e-05 | 50 | 181 | 5 | int:H4C3 | |
| Interaction | H2AX interactions | PCGF1 MCM2 BRD3 SIN3A ITGA2B NEB BMI1 MSH6 MDN1 GTF3C1 SUPT6H TONSL DKC1 SMARCE1 FH DNAH6 | 9.36e-05 | 593 | 181 | 16 | int:H2AX |
| Interaction | H3C8 interactions | 9.40e-05 | 27 | 181 | 4 | int:H3C8 | |
| Interaction | WHRN interactions | 9.40e-05 | 27 | 181 | 4 | int:WHRN | |
| Interaction | FBXO22 interactions | RIOK1 ACACB RTN4 OBSCN PSMC4 BRD3 NEB ERLIN2 MDN1 GTF3C1 AGA USP32 DIAPH2 RP1 ATP2A3 | 1.13e-04 | 540 | 181 | 15 | int:FBXO22 |
| Interaction | NANOG interactions | PCGF1 ACACB L3MBTL2 PSMC4 MUC16 MCM2 RELB SIN3A ORC5 MSH6 MDN1 SUPT6H ANGEL2 MOV10 | 1.18e-04 | 481 | 181 | 14 | int:NANOG |
| Interaction | H4C2 interactions | 1.22e-04 | 54 | 181 | 5 | int:H4C2 | |
| Interaction | H4C12 interactions | 1.22e-04 | 54 | 181 | 5 | int:H4C12 | |
| Interaction | H4C4 interactions | 1.25e-04 | 29 | 181 | 4 | int:H4C4 | |
| Interaction | OGT interactions | NOLC1 VIM SETD1A XRN2 ACOX1 RTN4 TOM1 CIR1 PSMC3 PSMC4 PPHLN1 SIN3A PDCD4 BMI1 DAZAP1 CIAO3 SMARCE1 ALAD HARS1 FH FKBP4 | 1.31e-04 | 950 | 181 | 21 | int:OGT |
| Interaction | CDKN3 interactions | 1.34e-04 | 55 | 181 | 5 | int:CDKN3 | |
| Interaction | G6PD interactions | 1.41e-04 | 214 | 181 | 9 | int:G6PD | |
| Interaction | SNW1 interactions | VIM XRN2 RIOK1 PDLIM7 CIR1 PSMC3 PSMC4 SIN3A EZH1 BMI1 ORC5 MSH6 MISP MDN1 VPS33B LRP2 HARS1 AQR | 1.42e-04 | 747 | 181 | 18 | int:SNW1 |
| Interaction | CAND1 interactions | SART3 XRN2 RIOK1 MYO10 MCM2 TSC2 CUL5 MRPL39 BMI1 BMPR1A DAZAP1 USP32 DKC1 SMARCE1 HSP90AB2P ATP1A2 DEPDC1B SEC23A SDHA MOV10 | 1.63e-04 | 894 | 181 | 20 | int:CAND1 |
| Interaction | H4C13 interactions | 1.72e-04 | 58 | 181 | 5 | int:H4C13 | |
| Interaction | NXF1 interactions | NOLC1 VIM XRN2 GNPDA1 VPS26B PDLIM7 GRK5 OBSCN PSMC3 PSMC4 PPHLN1 SIN3A SMYD2 CUL5 BMI1 PNPT1 SUPT6H ATP6AP2 DKC1 SMARCE1 RP9 HSP90AB2P HARS1 AQR SDHA TP53BP2 | 1.77e-04 | 1345 | 181 | 26 | int:NXF1 |
| Interaction | NOLC1 interactions | 1.79e-04 | 325 | 181 | 11 | int:NOLC1 | |
| Interaction | BCLAF1 interactions | NOLC1 SART3 MYO10 GRK5 RTN4 PPHLN1 APOBEC3B BMI1 RP1 CBX8 MOV10 | 1.88e-04 | 327 | 181 | 11 | int:BCLAF1 |
| Interaction | H2BC7 interactions | 1.91e-04 | 13 | 181 | 3 | int:H2BC7 | |
| Interaction | H2BC8 interactions | RIOK1 PCGF1 POLG MCM2 BRD3 ZNF226 PDCD4 ORC5 MSH6 GTF3C1 SENP6 SMARCE1 RP9 CBX8 SDHA | 2.28e-04 | 576 | 181 | 15 | int:H2BC8 |
| Interaction | SNCA interactions | SART3 VIM XRN2 GNPDA1 IARS1 ESYT1 GRK5 RTN4 LARS1 PSMC3 MCM2 SIN3A BMI1 MSH6 SVIL FKBP4 AQR | 2.59e-04 | 716 | 181 | 17 | int:SNCA |
| Interaction | MIR128-2 interactions | 2.71e-04 | 99 | 181 | 6 | int:MIR128-2 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.58e-05 | 34 | 121 | 4 | 487 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 9.13e-04 | 7 | 121 | 2 | 1208 | |
| GeneFamily | Ring finger proteins|Polycomb group ring fingers | 9.13e-04 | 7 | 121 | 2 | 61 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | NOLC1 RIOK1 IARS1 NOC3L LARS1 PSMC3 ISOC1 PSMC4 MCM2 MRPL45 APOBEC3B PDCD4 MRPL17 MRPL39 PNPT1 MSH6 MDN1 ERMAP DKC1 ALAD HARS1 FH DEPDC1B RPS6KL1 FKBP4 SDHA TP53BP2 | 2.26e-07 | 1271 | 182 | 27 | M39197 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | NOLC1 IARS1 ESYT1 MCM2 APOBEC3B FZD7 MSH6 DKC1 GREB1 TP53BP2 | 2.37e-07 | 164 | 182 | 10 | M13108 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 SART3 VIM L3MBTL2 ADAM23 ISOC1 MCM2 MSH6 FAM111A PTGR1 CDCA7 TONSL RPS6KA6 DKC1 ALAD DEPDC1B | 3.07e-06 | 578 | 182 | 16 | M2368 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 SART3 VIM L3MBTL2 ADAM23 ISOC1 MCM2 MSH6 FAM111A PTGR1 CDCA7 TONSL RPS6KA6 DKC1 ALAD DEPDC1B | 4.62e-06 | 597 | 182 | 16 | MM1309 |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 1.03e-05 | 197 | 182 | 9 | M7458 | |
| Coexpression | HU_FETAL_RETINA_MULLER | 1.06e-05 | 42 | 182 | 5 | M39267 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_MAC_DN | 1.12e-05 | 199 | 182 | 9 | M5246 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 1.12e-05 | 199 | 182 | 9 | M9173 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN | 1.16e-05 | 200 | 182 | 9 | M4533 | |
| Coexpression | GSE27786_BCELL_VS_CD8_TCELL_UP | 1.16e-05 | 200 | 182 | 9 | M4801 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_UP | 1.16e-05 | 200 | 182 | 9 | M5108 | |
| Coexpression | GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP | 1.16e-05 | 200 | 182 | 9 | M6305 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 1.16e-05 | 200 | 182 | 9 | M6556 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | NOLC1 PPP4R1 SART3 ATP7A RTN4 KDM3B PSMC3 TSC2 ITGA2B PDCD4 CUL5 FZD7 BMI1 ORC5 MSH6 NPTN PTPN13 DAZAP1 VPS33B ATP6AP2 DKC1 ALAD FH FKBP4 TP53BP2 | 1.39e-05 | 1399 | 182 | 25 | M535 |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | ANG ACACB SYTL2 TMEM101 PDCD4 BMI1 MISP NADSYN1 ERLIN2 SUPT6H ASPA NAV3 GREB1 ATP1A2 ATP2A3 AQR | 3.21e-05 | 699 | 182 | 16 | M4960 |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 7.16e-05 | 313 | 182 | 10 | M40228 | |
| Coexpression | BENPORATH_ES_1 | NOLC1 ADAM23 NOC3L MCM2 FZD7 MSH6 BMPR1A MDN1 ANGEL2 DIAPH2 ATP1A2 | 7.38e-05 | 379 | 182 | 11 | M1871 |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP | 7.47e-05 | 146 | 182 | 7 | M41190 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | NOLC1 PPP4R1 SART3 PDLIM7 IARS1 ISOC1 MCM2 BRD3 APOBEC3B SMYD2 MRPL17 MRPL39 MSH6 FAM111A DAZAP1 CDCA7 CIAO3 DKC1 HARS1 UBASH3B FH DEPDC1B MOV10 | 7.58e-05 | 1363 | 182 | 23 | M45782 |
| Coexpression | GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP | 7.94e-05 | 199 | 182 | 8 | M5753 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 8.22e-05 | 200 | 182 | 8 | M5851 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 8.22e-05 | 200 | 182 | 8 | M5870 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_DN | 8.22e-05 | 200 | 182 | 8 | M5118 | |
| Coexpression | GSE7764_NKCELL_VS_SPLENOCYTE_UP | 8.22e-05 | 200 | 182 | 8 | M5720 | |
| Coexpression | HU_FETAL_RETINA_RPC | 1.04e-04 | 107 | 182 | 6 | M39270 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_UP | ISOC1 MCM2 APOBEC3B SMYD2 BMI1 MSH6 NPTN FAM111A FBXO3 SPON1 ALAD HARS1 FKBP4 | 1.60e-04 | 561 | 182 | 13 | M1463 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | ACOX1 POLG CIR1 TSC2 EZH1 PDCD4 NADSYN1 GTF3C1 SUPT6H ATP6AP2 SVIL ALAD SDHA | 1.77e-04 | 567 | 182 | 13 | M16909 |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.75e-06 | 165 | 184 | 7 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 170 | 184 | 7 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 170 | 184 | 7 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 180 | 184 | 7 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 180 | 184 | 7 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 180 | 184 | 7 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 187 | 184 | 7 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 187 | 184 | 7 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 187 | 184 | 7 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-05 | 190 | 184 | 7 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | CV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 1.54e-05 | 192 | 184 | 7 | a249787f7e2f50af49bd7d4752c411a067a5e3d3 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 192 | 184 | 7 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-05 | 192 | 184 | 7 | 97c312c82ec025c13052f8d424b11c0034c8ea54 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-05 | 192 | 184 | 7 | 3b0a52e4e77ae4539a034dcb419773b8e2aa5d51 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-05 | 196 | 184 | 7 | 547901c7a665770eff78eede69b8625b416c8186 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-05 | 196 | 184 | 7 | 6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.94e-05 | 199 | 184 | 7 | cdcdef1d95a8e476de016b1e11ee010438834be0 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-05 | 150 | 184 | 6 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.99e-05 | 92 | 184 | 5 | 0754a79efc4c0659d9a2acfe4185bcae1a3e7206 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.99e-05 | 92 | 184 | 5 | aee1fd2419dc1fc7039c0ac56f0ba23ed11d668f | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 4.71e-05 | 156 | 184 | 6 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.06e-05 | 158 | 184 | 6 | a38345ffc5a7576ce99212bcbd620864a19de1fc | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.02e-05 | 163 | 184 | 6 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-05 | 165 | 184 | 6 | a6c6de17fec678ad0cac3138dde3a14cc39ffd26 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 6.88e-05 | 167 | 184 | 6 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 169 | 184 | 6 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-05 | 169 | 184 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.78e-05 | 178 | 184 | 6 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.78e-05 | 178 | 184 | 6 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.78e-05 | 111 | 184 | 5 | 4a22732094a9781867d501d9c05ba652c2f25048 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 184 | 6 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 184 | 6 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 181 | 184 | 6 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 181 | 184 | 6 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 184 | 6 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 181 | 184 | 6 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.07e-04 | 181 | 184 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 184 | 6 | 812ff2a50a510b18d865e89465dba1754a08ef61 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 183 | 184 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 183 | 184 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.14e-04 | 183 | 184 | 6 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | b12fb85a064f715a4f0ada1df8e422c359b573cf | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-04 | 184 | 184 | 6 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 185 | 184 | 6 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-04 | 185 | 184 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 185 | 184 | 6 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 185 | 184 | 6 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 185 | 184 | 6 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 186 | 184 | 6 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.24e-04 | 186 | 184 | 6 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 187 | 184 | 6 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 187 | 184 | 6 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-04 | 187 | 184 | 6 | cfdc1585c80d2bb475d9145395fb50a88c53f838 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-04 | 187 | 184 | 6 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 188 | 184 | 6 | 7e27e49ec1eb02fb74c86ec2ccb84751bc778b21 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 188 | 184 | 6 | 4b14c3ad80507245564d5be96d33fd9361f67dd0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.32e-04 | 188 | 184 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Kif5b_(Kif5b)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 63 | 184 | 4 | 50ea93ea08d8e7a1a2508e8a2c569f6f5dc91961 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Kif5b_(Kif5b)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 63 | 184 | 4 | c30197502348f07ded57ad4e50862e61e2fba51e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 189 | 184 | 6 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 189 | 184 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 189 | 184 | 6 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-04 | 190 | 184 | 6 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-04 | 190 | 184 | 6 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.40e-04 | 190 | 184 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 190 | 184 | 6 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 190 | 184 | 6 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-04 | 190 | 184 | 6 | 7179f980f895d3e5b839b5ae26b5c991787bfe3a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-04 | 190 | 184 | 6 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.44e-04 | 191 | 184 | 6 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.44e-04 | 191 | 184 | 6 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 191 | 184 | 6 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-04 | 191 | 184 | 6 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 191 | 184 | 6 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 191 | 184 | 6 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.44e-04 | 191 | 184 | 6 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 1.44e-04 | 191 | 184 | 6 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.44e-04 | 191 | 184 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 191 | 184 | 6 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 1.44e-04 | 191 | 184 | 6 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 192 | 184 | 6 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 184 | 6 | 3d777d07878269b87ec7e1f06489cae7c989d633 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.48e-04 | 192 | 184 | 6 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 192 | 184 | 6 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-04 | 193 | 184 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-04 | 193 | 184 | 6 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 122 | 184 | 5 | 2880f25d10a7765e55a2aa20c7a6ef74cea19c4d | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 122 | 184 | 5 | ecd0e54dd829201290212ea2ff7c8e7eec19c0e9 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 122 | 184 | 5 | cffd7730bda90828efc0def452cabb44cf93ab48 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.56e-04 | 194 | 184 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-04 | 194 | 184 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | HSPCs-Mk_prog.|HSPCs / Lineage and Cell class | 1.56e-04 | 194 | 184 | 6 | 5c05d508f5c29e6efe87506bf59e3b0fe5922f65 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.56e-04 | 194 | 184 | 6 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.56e-04 | 194 | 184 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 195 | 184 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.61e-04 | 195 | 184 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 3.66e-05 | 2 | 179 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | ALTERNATING HEMIPLEGIA OF CHILDHOOD 1 | 3.66e-05 | 2 | 179 | 2 | C3549447 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 3.66e-05 | 2 | 179 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | alternating hemiplegia of childhood (is_implicated_in) | 3.66e-05 | 2 | 179 | 2 | DOID:0050635 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | VIM PDLIM7 TMPRSS6 OBSCN XDH PPHLN1 APOBEC3B PDCD4 NME8 CUL5 MSH6 BMPR2 DAZAP1 ANKRD34A ZNF432 ATP2A3 CDH5 TP53BP2 | 1.01e-04 | 1074 | 179 | 18 | C0006142 |
| Disease | Alternating hemiplegia of childhood | 2.18e-04 | 4 | 179 | 2 | C0338488 | |
| Disease | vitamin D measurement, COVID-19 | 2.24e-04 | 49 | 179 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.96e-04 | 148 | 179 | 6 | C0279702 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | NOLC1 NRAP ANKUB1 SMYD2 STPG2 FZD7 MSH6 BMPR2 CDCA7 CADPS2 HPS5 CBX8 PDE11A SMG6 | 4.03e-04 | 801 | 179 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 7.53e-04 | 7 | 179 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Developmental Disabilities | 7.90e-04 | 30 | 179 | 3 | C0008073 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 1.00e-03 | 8 | 179 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | age at menarche | RBM12B MYO10 KDM3B DSCAML1 MSH6 PTGR1 SENP6 GREB1 CADPS2 MAST3 EVI5L | 1.06e-03 | 594 | 179 | 11 | EFO_0004703 |
| Disease | Colorectal Carcinoma | CPAMD8 MYOT RTN4 OBSCN NTNG1 DSCAML1 KCNH4 MSH6 BMPR1A ZNF432 LRP2 CDH5 | 1.26e-03 | 702 | 179 | 12 | C0009402 |
| Disease | epilepsy (is_implicated_in) | 1.28e-03 | 9 | 179 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | cysteine measurement | 1.28e-03 | 9 | 179 | 2 | EFO_0021000 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.35e-03 | 36 | 179 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | VIM XRN2 SETD1B L3MBTL2 TMPRSS6 RTN4 MCM2 BRD3 RELB APOBEC3B BMPR2 VPS33B CDCA7 ERMAP DKC1 USP4 RP1 MAST3 | 1.46e-03 | 1347 | 179 | 18 | EFO_0005192 |
| Disease | cancer antigen 125 measurement | 1.59e-03 | 10 | 179 | 2 | EFO_0010603 | |
| Disease | osteosarcoma (is_marker_for) | 1.94e-03 | 11 | 179 | 2 | DOID:3347 (is_marker_for) | |
| Disease | Seizures | 2.21e-03 | 218 | 179 | 6 | C0036572 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.27e-03 | 43 | 179 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 2.32e-03 | 12 | 179 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | inflammatory bowel disease (is_marker_for) | 2.32e-03 | 12 | 179 | 2 | DOID:0050589 (is_marker_for) | |
| Disease | Carcinoma, Neuroendocrine | 2.32e-03 | 12 | 179 | 2 | C0206695 | |
| Disease | granulins measurement | 2.32e-03 | 12 | 179 | 2 | EFO_0008141 | |
| Disease | Degenerative polyarthritis | 2.51e-03 | 93 | 179 | 4 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 2.51e-03 | 93 | 179 | 4 | C0086743 | |
| Disease | transferrin receptor protein 1 measurement | 3.17e-03 | 14 | 179 | 2 | EFO_0802142 | |
| Disease | brain connectivity measurement | 3.19e-03 | 400 | 179 | 8 | EFO_0005210 | |
| Disease | Generalized seizures | 3.38e-03 | 101 | 179 | 4 | C0234533 | |
| Disease | Clonic Seizures | 3.38e-03 | 101 | 179 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 3.38e-03 | 101 | 179 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 3.38e-03 | 101 | 179 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 3.38e-03 | 101 | 179 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 3.38e-03 | 101 | 179 | 4 | C0751123 | |
| Disease | Complex partial seizures | 3.38e-03 | 101 | 179 | 4 | C0149958 | |
| Disease | Single Seizure | 3.38e-03 | 101 | 179 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 3.38e-03 | 101 | 179 | 4 | C3495874 | |
| Disease | Visual seizure | 3.38e-03 | 101 | 179 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 3.38e-03 | 101 | 179 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 3.38e-03 | 101 | 179 | 4 | C0422855 | |
| Disease | Gustatory seizure | 3.38e-03 | 101 | 179 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 3.38e-03 | 101 | 179 | 4 | C0422850 | |
| Disease | Olfactory seizure | 3.38e-03 | 101 | 179 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 3.38e-03 | 101 | 179 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 3.38e-03 | 101 | 179 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 3.38e-03 | 101 | 179 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 3.38e-03 | 101 | 179 | 4 | C4317109 | |
| Disease | Absence Seizures | 3.51e-03 | 102 | 179 | 4 | C4316903 | |
| Disease | Convulsions | 3.51e-03 | 102 | 179 | 4 | C4048158 | |
| Disease | Tonic Seizures | 3.51e-03 | 102 | 179 | 4 | C0270844 | |
| Disease | Proteinuria | 3.65e-03 | 15 | 179 | 2 | HP_0000093 | |
| Disease | hepcidin:transferrin saturation ratio | 3.65e-03 | 15 | 179 | 2 | EFO_0007902 | |
| Disease | osteoarthritis (implicated_via_orthology) | 3.65e-03 | 15 | 179 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Seizures, Focal | 3.76e-03 | 104 | 179 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 3.76e-03 | 104 | 179 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 3.76e-03 | 104 | 179 | 4 | C0494475 | |
| Disease | IGFBP-3 measurement | 4.34e-03 | 54 | 179 | 3 | EFO_0004626 | |
| Disease | Meningioma | 5.85e-03 | 19 | 179 | 2 | C0025286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PYGDSMDRIEKDRLQ | 511 | Q9UMD9 | |
| YRLRELFKPSMAELG | 226 | Q96CN4 | |
| EDYMDGLAIRSKPLR | 701 | Q86US8 | |
| SIYMERAEDLPLRKG | 801 | Q9BSJ8 | |
| VKRKMDGREYPDAQG | 361 | Q15059 | |
| MDGDRGKPNRILYSL | 271 | Q96JP9 | |
| QLDSPKALYLGRVME | 1176 | P78357 | |
| RAVNPSRGIFEEMKY | 286 | O75077 | |
| GMDIEATNRDYKRPL | 61 | Q6P6B7 | |
| REVGMPADYVNKLAR | 481 | Q93034 | |
| DPLYKEALQMLRDAG | 316 | Q9UH17 | |
| RRVQIKYPGADMDIT | 411 | Q8WUY9 | |
| KMDPEAREQAYQERR | 206 | O60306 | |
| YVMNAEGDEPSSKRR | 111 | Q5VTE6 | |
| NVDPYERDQLRVKME | 316 | P07384 | |
| SGMDPDFKYRQRLDI | 461 | O60879 | |
| AAALGYRERLDMAPD | 716 | Q8IYB7 | |
| EVVMIYDAEKQRPRG | 141 | Q96EP5 | |
| RFKMLAELYGSDPRE | 766 | P33151 | |
| EYRRKENGVNSPRMD | 111 | Q13625 | |
| EYEPEMGKVIRSDRK | 121 | Q93084 | |
| KARMVRYLLEQGADP | 56 | Q69YU3 | |
| VALMAGKAEVRYNPA | 521 | Q04656 | |
| REYFNSEKPEGRIIM | 346 | Q6P1R3 | |
| DMALYVPKARRGAVL | 16 | Q7Z5L2 | |
| YNEAMAAIKDLNDRP | 976 | Q8IXT5 | |
| MADAGIRRVVPSDLY | 1 | Q14978 | |
| KRPRVIVDYNENMGA | 416 | Q96DM1 | |
| EQPKQRGMRFRYECE | 131 | Q01201 | |
| ELIGDGMERDYRAIP | 71 | P49736 | |
| MARAEGIPKIYVAAN | 1816 | O00763 | |
| MKTYRLDAGDADPRR | 121 | Q8IVT2 | |
| YEEDMRRPGSRKFNT | 13336 | Q8WXI7 | |
| DMQERFRPAIKYFGD | 121 | Q96CN7 | |
| DGYMLLAGRVRKQEE | 1301 | Q9NU22 | |
| LMQAIDAVKPGVRYR | 256 | P53582 | |
| LRMDDPKGDFITLYQ | 281 | Q8TC57 | |
| VKTFNMDEYVGLPRD | 66 | P46926 | |
| DRGMSRKPEDLYVRR | 1436 | Q4ZG55 | |
| KEQMVDASRPELLYR | 246 | P26572 | |
| LQIGYRSVDDDPRMK | 1561 | Q86VF7 | |
| YPFRQGMRLEVVDKS | 321 | Q969R5 | |
| PGVARYGVKRLEEML | 51 | P13716 | |
| KRDSRVVYMTEPIDG | 281 | Q58FF8 | |
| QERRGKPEQMYVSSE | 106 | Q9UPZ3 | |
| ATYRKLVEGEEGRMD | 381 | Q6KB66 | |
| EEVNDKRYLRCPAAM | 156 | P35226 | |
| FRVSIARLEMGPDEY | 406 | Q9UK99 | |
| MKRGYERIYNEIPDI | 401 | Q53EL6 | |
| DRHPELFEDYLMRKG | 16 | Q9HCR9 | |
| EAVREGLQMYGKRTP | 2271 | Q8IVL0 | |
| MERRYGIPQGEALDI | 1206 | P54098 | |
| IREQFPGSEMEKYAL | 1656 | Q9HD67 | |
| MENLPLPEYTKRDGR | 1506 | Q7LBC6 | |
| YVIGRREMEANDPLL | 381 | Q9UQ05 | |
| NMAGAKLYDLPVDER | 151 | P16050 | |
| KRDPSEEIEILMRYG | 461 | Q9UK32 | |
| GTDRRVIAKEAMNPY | 4261 | P98164 | |
| KPQGRDDRYCESIMR | 41 | P03950 | |
| PMRKSYRGDREAFEE | 36 | Q9NVS9 | |
| VFPEDMAKYRSIRGE | 116 | Q9BTT4 | |
| YSAKPEILRAMQRAD | 166 | P52701 | |
| KTPIRNRAFYMEEGV | 371 | Q9NR12 | |
| GKNMYINRDRIPEER | 241 | Q8TAG9 | |
| KMVQPRRDGYFEGIE | 1596 | Q96JM4 | |
| PEAIRRNYELMESEK | 176 | O94905 | |
| PGDKYSLRQEGAMLE | 3226 | Q5VST9 | |
| QLAPSEERVYMVGKA | 126 | O75787 | |
| PGRANGLMYFKEEER | 236 | O75084 | |
| DNGYLKMDNHRIPRE | 236 | Q15067 | |
| YEAAESDIMKRQPRN | 821 | P50993 | |
| IFVDDLNMPRLDRYG | 2161 | Q9C0G6 | |
| EQMINVAREKYRPVA | 3281 | Q9C0G6 | |
| AFEEREREMELYGPK | 56 | Q9HC52 | |
| LKRPYVDEFLRRMGE | 141 | O14595 | |
| PDRVMRYAIATKDNG | 831 | Q8TD84 | |
| DEGPEMLEKQRNLYI | 676 | Q14CM0 | |
| RIKAAMPRIYELAAG | 261 | P07954 | |
| GRYFQVEVEKRMVPS | 261 | Q96PZ2 | |
| EKLEAYILDPRGSRM | 161 | Q8IZJ3 | |
| ADRYKAIVRPMDIQA | 136 | P30550 | |
| IRMGQEPGVAKYRRA | 106 | O75508 | |
| RYMAPEVLEGAVNLR | 381 | Q13873 | |
| RVGTKRYMAPEVLDE | 401 | P36894 | |
| YRGEEDLCKQPNRMA | 211 | Q86UW7 | |
| PVRVDEFKYQMTRTG | 141 | Q9UI17 | |
| YRERFPKATAQMEGR | 176 | O60307 | |
| EDPNDNRYLLVMKGA | 486 | P13637 | |
| QAVEYMRRGEDPTIA | 271 | P20933 | |
| GKERMYEENSQPRRN | 136 | P22681 | |
| RKDSSYELQVRAGPM | 191 | Q9HBE5 | |
| SAEEGYVKMFLRGRP | 181 | O00423 | |
| REGFKLLMEPEYANI | 426 | Q6ZQY3 | |
| PYGLERAIQRMEKGE | 201 | Q02790 | |
| INDRQMPKVEYRDIE | 586 | P42658 | |
| PARNVEAGAYVEMIR | 311 | Q6P6B1 | |
| YEMIEGQSPFRGRKE | 376 | P34947 | |
| RDMDLNYRGMLIPEE | 261 | Q96Q07 | |
| ESKMIEYDPERRLGI | 201 | O60832 | |
| YIDFEMKIGDPARIQ | 316 | Q15020 | |
| GTRDYSPRQMAVREK | 61 | P12081 | |
| QPEYRDMRDGFRRKS | 96 | Q8NEY8 | |
| LREAMNVEEPVRRYK | 391 | Q12923 | |
| SVYKMDPLRNEEEVR | 21 | Q9BSM1 | |
| VDPYMRVAAKRLKEG | 46 | Q14914 | |
| SGFVKGRNYEVRPEM | 406 | Q8WTT2 | |
| GRNYEVRPEMLKTFL | 411 | Q8WTT2 | |
| YKDQGPRRAEILDEM | 486 | Q9Y6K5 | |
| QPMNEEDRGFAYRKE | 1926 | P56715 | |
| RPDQMILEKSLDYGR | 156 | Q9Y2I2 | |
| MPEYKGRTVLVRDAQ | 91 | Q96PL5 | |
| PRTLNEVKNYERDMD | 431 | Q9BRS2 | |
| EKRVAVEAPMREEYA | 371 | Q9NQC3 | |
| AENRGEMKLALQYVP | 766 | Q9HCH5 | |
| RAFKDEYMVNLVRAP | 156 | Q9NYK5 | |
| MRSRERYVKQFPEDG | 521 | Q9HCB6 | |
| AHEDPMYDIIRDNKR | 136 | Q8TA86 | |
| QDEMLTPLGRLDKYA | 41 | Q8TF05 | |
| VQKYLGEGPRMVRDV | 236 | P43686 | |
| ESRQRQSRMEKGEPY | 156 | Q969G3 | |
| RRDRKAYDCMLQDPG | 1981 | O95425 | |
| IYRVAGKNMAPLEAL | 96 | Q5T4T1 | |
| SQGERFMERYAPVAK | 321 | P31040 | |
| RPDRAKGYDLELSMA | 276 | Q9HCE1 | |
| DRFGRLMYGQEDVPK | 226 | Q9BRJ2 | |
| ALRAKYGIRDDMVLP | 411 | Q9P2J5 | |
| KAEYLRDMEANLLPG | 126 | O43913 | |
| MKRRLDDQESPVYAA | 1 | Q96ST3 | |
| GPRGRDEVTEEYMEL | 1621 | Q9UPS6 | |
| NKYGIRLRAEPDHMV | 886 | P41252 | |
| PMDVVKSRLQADGVY | 236 | Q6ZT89 | |
| APLYMESRADRKLAE | 341 | P08514 | |
| MPLVVDYRQKAAAAG | 96 | Q8TCS8 | |
| IQVKYFGRDPADGRM | 731 | Q8TCS8 | |
| VADMREKRYVQEGIG | 1606 | O15047 | |
| IRDYSPGMRPEQKEA | 831 | Q7RTU9 | |
| MARLAIYRAETEEGP | 526 | Q15436 | |
| KMSEDLPYEVRRAQE | 81 | P45381 | |
| PLSEDKQGRRYLELM | 36 | A6NFN9 | |
| RKTVDGYMNEDDLPR | 211 | Q9BWT1 | |
| ERLYGMVRAEAPEDA | 421 | Q9H6Q4 | |
| YEDVARGPLQKAREM | 371 | Q7LGC8 | |
| GAPREKYAKDDMNIR | 101 | Q86X95 | |
| EQRKPMEYAPRDGIL | 211 | Q8NCR9 | |
| RDVQALRDMVRKEYP | 56 | Q9BTX7 | |
| EGARYMVALQIAREP | 586 | Q7KZ85 | |
| DTIAKYEIMDGAPVR | 226 | Q4G0F5 | |
| RDNPLGMKGEIAEAY | 341 | Q13107 | |
| KRLEPAQRDLYRDVM | 66 | P17036 | |
| EERKIAAGEMARPQY | 116 | Q8N427 | |
| IDKQGIDRDRYMEPV | 421 | O60687 | |
| RGPSAMEYNKEDRES | 386 | Q71H61 | |
| YEDLRRKGLEFPMTD | 141 | O60784 | |
| MYDRAPRLLKLAEGG | 1 | Q8N412 | |
| RKIGERLAEMEDYPA | 71 | Q96HA7 | |
| RVKAMEVDERPTEQY | 171 | P17980 | |
| QFRYKDMTGPREALD | 166 | Q96GC6 | |
| RLLYMAIDGVAPRAK | 96 | Q9H0D6 | |
| PGEGEHKIMDYIRRQ | 201 | Q9H0D6 | |
| ENGVPDDMKERYREL | 246 | Q92800 | |
| MEYRINKPRAEDSGE | 201 | Q9Y639 | |
| RMFGAYGEPEERRDV | 11 | A0A1W2PR48 | |
| QGKSRLGDLYEEEMR | 141 | P08670 | |
| DPGQKALYRDVMLEN | 26 | Q76KX8 | |
| IRLNYSDESPEAGKM | 911 | Q9GZR1 | |
| GMPAEEVRRKNLYKE | 936 | P47989 | |
| RVALGVPDMTKRDYL | 36 | Q9Y6S9 | |
| ENPEDTYERRIMVDK | 146 | Q8IYK8 | |
| VLRTDPRYEDVKNMN | 201 | Q9H8X9 | |
| RKEEMGALYVEEPRT | 1116 | O60290 | |
| GPAQRKLYRDVMVEN | 26 | Q9NYT6 | |
| GPFQKDLYRDVMLEI | 26 | O94892 | |
| GPAQKDLYRDVMLEN | 26 | Q6PF04 | |
| IRDYSPGMRPEQKEA | 831 | A6NGW2 | |
| GMAAREELYSKVTPR | 11 | Q8TF42 | |
| VLRTDPRYEDVKNMN | 201 | P0C7U3 | |
| AMRYRALIGQEGDPD | 156 | Q12789 | |
| PKAEAIRDMVRYARN | 286 | Q9NRG4 | |
| EQHRGERYKDMVDPK | 611 | Q9UN76 | |
| TTPVRYGLRLNMDEK | 931 | Q8NFA0 | |
| RVDGEYDLKVPRDMA | 496 | Q9H267 | |
| KGLNEGYDRRPLASM | 346 | Q9P2T0 | |
| EDRAYMEDAPLLRGA | 281 | P49815 | |
| RLAMYDVAGPLEKRL | 271 | Q8IU80 | |
| PNRSLDRAKMAVIEY | 111 | Q9NRX2 | |
| MLYAERAEARRKPDI | 36 | Q96IK0 | |
| IRPKMALANEGNYRE | 111 | Q6IA69 | |
| YEEKMARRLLGPQNA | 181 | Q9UBF9 | |
| QGKAAYVLDTPEMRR | 6411 | P20929 |